Skip to main content
Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Ycf93 (Orf105), a Small Apicoplast-Encoded Membrane Protein in the Relict Plastid of the Malaria Parasite Plasmodium falciparum That Is Conserved in Apicomplexa


Malaria parasites retain a relict plastid (apicoplast) from a photosynthetic ancestor shared with dinoflagellate algae. The apicoplast is a useful drug target; blocking housekeeping pathways such as genome replication and translation in the organelle kills parasites and protects against malaria. The apicoplast of Plasmodium falciparum encodes 30 proteins and a suite of rRNAs and tRNAs that facilitate their expression. orf105 is a hypothetical apicoplast gene that would encode a small protein (PfOrf105) with a predicted C-terminal transmembrane domain. We produced antisera to a predicted peptide within PfOrf105. Western blot analysis confirmed expression of orf105 and immunofluorescence localised the gene product to the apicoplast. Pforf105 encodes a membrane protein that has an apparent mass of 17.5 kDa and undergoes substantial turnover during the 48-hour asexual life cycle of the parasite in blood stages. The effect of actinonin, an antimalarial with a putative impact on post-translational modification of apicoplast proteins like PfOrf105, was examined. Unlike other drugs perturbing apicoplast housekeeping that induce delayed death, actinonin kills parasites immediately and has an identical drug exposure phenotype to the isopentenyl diphosphate synthesis blocker fosmidomycin. Open reading frames of similar size to PfOrf105, which also have predicted C-terminal trans membrane domains, occur in syntenic positions in all sequenced apicoplast genomes from Phylum Apicomplexa. We therefore propose to name these genes ycf93 (hypothetical chloroplast reading frame 93) according to plastid gene nomenclature convention for conserved proteins of unknown function.


The widely used malaria prophylactic, doxycycline, was originally developed as an antibacterial that blocks protein translation by prokaryotic ribosomes [1]. Efficacy against malaria is believed to result from inhibition of translation in the relict plastids (apicoplast) of malaria parasites [2]. Other inhibitors of prokaryotic translation, plus inhibitors of apicoplast DNA replication (fluoroquinolones like ciprofloxacin) are also paraciticidal [2], [3]. Indeed, any perturbation of apicoplast housekeeping appears to kill malaria parasites [2], [3]. This highlights the importance of the maintenance of the apicoplast for parasite survival.

Apicoplasts arose by secondary endosymbiosis of a red alga within the common ancestor of Apicomplexa and dinoflagellates [4]. Most dinoflagellates remain photosynthetic, but Apicomplexa adopted a parasitic lifestyle and dispensed with photosynthesis [5], [6]. The endosymbiotic organelle, however, persists and is indispensable [7]. The apicoplast of the human malaria parasite Plasmodium falciparum has a small (35 kb), circular genome similar to that of most plastids; the major difference being that the apicoplast genome encodes no genes for photosynthesis [8]. Thirty putative protein-encoding genes have been identified on the P. falciparum apicoplast genome, and seven of these are hypothetical proteins (open reading frames >50 amino acids) [8]. With the exception of SufB/ORF470, which has a role in the formation of iron∶sulphur clusters, and ClpC, a protein chaperone subunit with a possible role in protein import [9], all apicoplast genes with known roles are devoted to expression of the genome (housekeeping) [8]. Further information of the roles of these genes, particularly the hypothetical ones, could thus be valuable in targeting apicoplasts in the battle against malaria.

To explore the roles of hypothetical apicoplast proteins we attempted to generate antisera to predicted peptides from a selection of the hypothetical apicoplast genes (ORFs) that possibly encode proteins. Here we describe the characterization of one previously hypothetical apicoplast protein – Orf105/PfYcf93 - to which we generated a successful antiserum allowing us to localize the protein to the apicoplast membranes, document its turnover during the cell cycle, and explore effects of a post-translation inhibitor on the apicoplast and PfYcf93. We also searched for homologues of Pfycf93 in the apicoplast genomes of other apicomplexan parasites and related photosynthetic symbionts of corals such as the chromerids Chromera velia and Vitrella brassicaformis.

Results and Discussion

PfYcf93 is an apicoplast-encoded protein

orf105 is an open reading frame (366 nucleotides) located on the IR-B section of the 35 kb circular genome of the apicoplast of P. falciparum (GenBank: X95276.2) that encodes a hypothetical protein of 121 amino acids [8]. The name orf105 stems from a previous annotation for a shorter version of the protein that invokes a downstream Met based on the presence of a transcribed and processed trnS gene within the N-terminus of the 121 amino acid open reading frame [10]. In keeping with plastid gene nomenclature convention for gene products conserved in multiple species [11] we designated the gene ycf93 (hypothetical chloroplast open reading frame 88) because orthologues occur in numerous Apicomplexa (see below).

Goat antisera raised against a 14-residue peptide (NILLKSKNSNNYIY) were used for immunofluorescence on in vitro cultured blood stage P. falciparum parasites (Fig. 1A). Antigen (red) was localized to a small punctum (Fig. 1A). Co staining (green) with antisera to the apicoplast marker acyl carrier protein (ACP) [12] showed the antigen recognised by our goat antiserum co localized with the apicoplast adjacent to the nucleus (Fig. 1A). We conclude that the peptide antisera recognises an antigen located in the apicoplast.

Figure 1. Characterization of Pfycf93 gene product in Plasmodium falciparum.

A) Localization in the apicoplast of an antigen recognised by PfYcf93 peptide antisera. PfYcf93 (red) localises to a small punctum that overlaps with the apicoplast marker acyl carrier protein (green) and sits beside the nucleus (blue) in a small, ring-stage parasite within a red blood cell. Bar = 1 µm. B) Western blot of SDS-PAGE separated proteins labelled with either pre-immune or immune sera demonstrates specific labelling of a 17.5 kDa protein. C) Labelling of the 17.5 kDa protein with the peptide antiserum is abrogated by pre-incubation of the membrane with 10 mg/ml of peptide. D) PfYcf93 protein partitions into the pellet during Triton X-114 partitioning, and a second band of 35 kDa is apparent. E) Western blotting of the 17.5 kDa band across the 48 hour asexual red blood cell cycle of synchronized parasites demonstrates that Pfycf93 is not detectable at 0, 4, or 12 hours but begins to be detectable at 16 hours and then increases in abundance from 20 to 40 hours and then decreases again at 44 and 48 hours. The change in abundance of the 17.5 kDa band is similar to published fluctuations of merozoite surface protein 1 (MSP-1), but contrasts to MSP-8 and apical merozoite antigen 1 (AMA-1), which have very different turnover patterns. Giemsa stained images of parasite development at different time points are shown. Loading was normalised by protein amount and equal loading confirmed by Ponceau staining (data not shown).

PfYcf93 is an apicoplast membrane protein and may form dimers

Western blotting using the peptide antisera identified a single band of 17.5 kDa (Fig. 1B), which is in reasonable agreement with the predicted mass for PfOrf105/PfYcf93 of 15 kDa. Controls with pre-immune sera did not decorate any bands (Fig. 1B). Specificity of the antisera for PfYcf93 was verified by pre-incubation of the antiserum with 10 mg/ml peptide, which abrogated binding to the 17.5 kDa band (Fig. 1C). We conclude that the antiserum is specific for the gene product of the apicoplast gene Pforf105, confirming it as a protein-encoding gene, which we rename Pfycf93.

PfYcf93 protein partitions into the detergent phase during Triton X-114 phase partitioning [13], indicating that it is a membrane protein (Fig. 1D). This membrane localization confirms the bioinformatic predictions of a single C-terminal transmembrane domain. In detergent partitioned non-denaturing Western blots, a second major band of apparent molecular mass 37 kDa was observed (Fig. 1D), indicating that PfYcf93 may exist as a dimer. Based on the immunofluouresence, Western blots, and detergent partitioning we conclude that Pfycf93 encodes a small apicoplast membrane protein. Considering the apicoplast appears to lack any systems such as YidC/Oxa/Alb3 chaperone family proteins involved in insertion, export or assembly of membrane proteins [14], [15], it seems most likely that PfYcf93 is located in the innermost of the four bounding membranes and self inserts.

PfYcf93 undergoes turnover

During the 48-hour life cycle of malaria parasites the apicoplast undergoes dramatic growth, branching, and division resulting in the distribution of an apicoplast into each daughter merozoite [16]. We monitored the steady state levels of PfYcf93 protein across the life cycle by Western blot on a synchronous culture of P. falciparum (Fig. 1E & 2A). In the initial part of the life cycle just following invasion (0 hours), the so-called ring stage parasites did not have any detectable PfYcf93 (Fig. 1E). After 4 hours (early rings) and 12 hours (early trophozoites) PfYcf93 was still not detectable (Fig. 1E). At 16 hours a faint PfYcf93 band had developed, and by 20 hours (late trophozoites) there was a robust PfYcf93 band, which persisted right through the trophozoite phase and into schizogony but then decreased at 44 hours and still further at 48 hours (Fig. 1E). By comparison, probing of the same samples with antibodies to the merozoite surface protein 1 (MSP1) confirms previous reports that MSP1 only begins to be expressed at 32 hours and persists through to early rings (0 hours and 4 hours). Conversely, merozoite surface protein 8 (MSP8) shows a restricted window of expression between 4 and 24 hours, as previously described [17], and the apical merozoite antigen (AMA1) has maximal expression in the shizont/merozoite phase (36 – 0 hours) as described [18].

Figure 2. The effects of the prokaryotic post-translational modification inhibiting drug actinonin on PfYcf93 turnover and apicoplast development and cytokinesis.

A) Western blot showing the effect of actinonin and the isoprenoid precursor synthesis inhibitor fosmidomycin on steady state levels of PfYcf93 over one life cycle. Treatment with these drugs abrogates the normal turnover of PfYcf93 observed during schizont (40 hour) to ring (56 hour) transition. Loading controls at each life cycle stage using anti-BiP are shown in the lower panels. B) Effect of the putative post-translational inhibitor actinonin on biogenesis of the apicoplast, mitochondria and nuclei. Live cell imaging of untreated parasite with red fluorescent apicoplast, green fluorescent mitochondrion and blue fluorescent nuclei shows the normal branching/division of the apicoplast, elaboration of the mitochondrion and multiplication of the nucleus at the schizont stage. Actinonin-treated parasite at the same stage shows a branched mitochondrion and multiple nuclei but an undeveloped, stunted apicoplast (arrow). C) Effect of fosmidomycin and actinonin on the apicoplast and parasitophorous vacuole (P.V.) at the schizont stage. Immunofluorescence assay of untreated parasite with red fluorescent apicoplast (anti-ACP), green P.V. and blue fluorescent nuclei shows the segregation of the apicoplast, nuclei into distinct merozoites during late schizont stage. Actinonin or fosmidomycin treated parasites at the same stage show multiple nuclei but an undeveloped apicoplast and severe disruption of internal membrane structure in the parasite.

The drastic disappearance of PfYcf93 protein toward the latter part of schizogony (Fig. 1E & 2A) suggests that PfYcf93 undergoes degradation, probably during the late stage of formation of merozoites. This is the first clear example of protein turnover within apicoplasts. Plastids of plants undergo substantial protein turnover due to activity of a range of proteases, most of which are inherited from the cyanobacterial endosymbiotic ancestor of plastids [19]. Three apicoplast proteases (signal processing peptidase [SPP] [20], falcilysin/PreP [21], and caseinolytic protease (Clp) [9], [22], [23]) have been identified in Plasmodium. SPP and PreP are believed to have roles in processing of leader peptides that mediate import of nucleus-encoded proteins into the apicoplast [20], [21], so Clp is the prime candidate for turnover of PfYcf93.

Is PfYcf93 subject to post-translational modification?

Like bacteria, plastids use a formyl methionine as the initiator Met for proteins encoded by the plastid genome and synthesised within the plastid [24]. The formyl group is added to the initiator methionine by formyl methionine transferase (FMT) and is later removed from the methionine by peptide deformylase (PDF) after translation [24]. In select instances (depending on the identity of the second amino acid) the deformylated methionine itself is then removed by methionine aminopeptidase (MAP) [24], which influences protein stability [25]. Genes for likely apicoplast FMT, PDF and MAP have been identified in Plasmodium falciparum [14], [26] and PfPDF is indeed targeted to the apicoplast [27] suggesting homologous N-terminal processing occurs in the apicoplast. Several drugs inhibit PDF [28][32] and one, actinonin, has been noted to have antimalarial activity [33]. Recombinant PfPDF has been expressed and its structure determined [34]. Activity of recombinant PfPDF is inhibited by actinonin in in vitro assays [34]. Four apicoplast-encoded proteins from P. falciparum (Rps3, Rpl16, Orf91 and Orf105/Ycf93) contain the correct amino acid at residue two [8] to potentially undergo removal of the N-terminal methionine after deformylation by PfPDF. We therefore decided to explore the effect of actinonin on parasite growth, the N-terminus of PfYcf93, and the turnover of PfYcf93 during the asexual red blood cell cycle.

In vitro culture drug trials of P. falciparum 3D7 confirmed reports [33] that the PDF inhibitor actinonin is parasiticidal with an IC50 of 4.9 (±1.05) µm for a 48 hour growth assay. Drugs targeting apicoplast housekeeping activities (DNA replication, RNA transcription, and protein translation) typically result in the curious phenomenon known as delayed death in apicomplexan parasites [3], [7]. Delayed death alludes to the fact that the drugs have minimal effect during the cell cycle in which they are applied, but exhibit maximal lethality during the subsequent cell cycle, even if the drugs have been removed after exposure in the initial cycle [3], [7], [35][37]. How this phenomenon works remains uncertain, but the leading hypothesis is that a stockpile of some factor essential to a successful invasion of fresh host cells for the second cell cycle must be accumulated during the first cell cycle, when the drugs take effect [14]. Since actinonin would theoretically be an inhibitor of post-translational modification, we decided to trial its activity over two asexual red blood cell cycles to test for delayed death. Intriguingly, the IC50 of 2.7 (±0.15) µm for 96 hours (two cycles) shows only a modest decrease in comparison with the IC50 of 4.9 (±1.05) µm over 48 hours (one cycle), suggesting that actinonin does not cause classic delayed death.

Since the putative post-translational inhibitor actinonin was not inducing the anticipated delayed death response, we decided to explore the effect of this inhibitor on turnover of PfYcf93. Exposure to 20 µM actinonin prevented the degradation of PfYcf93 that normally occurs during the conversion from schizonts to merozoites then rings between 40 and 56 hours after invasion in the asexual erythrocyte life cycle (Fig. 2A). However, interpretation of the impact of actinonin on turnover of PfYcf93 is complicated by the fact that this drug also impairs progression though the cell cycle. We exposed parasites with red fluorescent apicoplasts, green fluorescent mitochondria [16] and blue fluorescent DNA to 20 µm actinon and undertook live cell imaging to observe the effect of the drug on organelle development and schizogony (Fig. 2B). Under actinonin drug pressure, apicoplast development and parasite progression through schizogony are both blocked (Fig. 2B). Actinonin treatment of parasites reveals drastic retardation of apicoplast development. At the late trophozoite stage the apicoplast is normally highly branched forming a network around the nuclei [16], but actinonin-treated apicoplasts failed to develop and remained small and rounded, like they are in ring stages (Fig. 2B). Intriguingly, there is virtually no discernible impact of actinonin on the division of mitochondria and nuclei, which branch and divide respectively as normal (Fig. 2B and 2C). There is, however, a marked impact of actinonin treatment on merozoite development; a marker for the parasitophorous vacuole showed drastic defects in membrane structure at the late schizont stage resulting in a failure to undergo cytokinesis (Fig. 2C). We conclude that actinonin blocks apicoplast growth and division, including the turnover of PfYcf93, likely through inhibition of PfPDF in the apicoplast, though that remains to formally proven.

Immediate death and specific inhibition of apicoplast development in P. falciparum (and P. berghei) also occurs with exposure to the drug fosmidomycin [38], which inhibits the production of isopentenyl diphosphate [39], an essential product of apicoplasts in the red blood cell stage of the parasite life cycle [40]. We examined the impact of fosmidomycin on PfYcf93 turnover and observed the same effect as actinonin - abrogation of turnover (Fig. 2B). Similarly, fosmidomycin also blocked apicoplast growth, perturbed schizogony and the appropriate segmentation of the parasitophorous vacuole (Fig. 2C). The remarkable similarity of the drug response phenotypes for actinonin and fosmidomycin perhaps suggests that actinonin perturbs synthesis of isopentenyl diphosphate, but this remains to be established.

Whether or not actinonin impacts directly on PfYcf93 turnover is difficult to conclude since impairment of apicoplast development by either actinonin or fosmidomycin might indirectly prevent stage specific turnover simply by blocking stage progression. We attempted to determine the actual N-terminus of PfYcf93 with and without actinonin by immunoprecipitating the protein and N-terminal sequencing by Edman degradation to explore any N-terminal processing by PDF/MAP, but found the N-terminus to be blocked (data not shown). N-terminal blockage for Edman degradation occurs frequently when attempting to sequence proteins [41] and cannot be inferred to result from PDF modification or lack thereof.

Ycf93 protein family in Apicomplexa

Apicoplast genomes are available for 14 apicomplexan parasites, namely nine species of the Haemosporida genus Plasmodium [8], [42], [43], one bird Haemosporida (Leucocytozoon caulleri [44]), two Coccidia (Eimeria tenella [45] and Toxoplasma gondii [46]), and two Piroplasmida (Babesia bovis [47], [48] and Theileria parva [49]). We examined the IR-B region (or equivalent) of these genomes plus that of the related chromerid algae Vitrella brassicaformis [50] and Chromera velia [51] for possible orthologues of ycf93/orf105. Syntenic orthologues of Pfycf93 with clear sequence identity exist in all sequenced apicoplast genomes of Plasmodium spp. plus Leucocytozoon caulleri (Figs. 3 and 4). The Plasmodium spp. and L. caulleri Ycf93 proteins all contain a predicted C-terminal trans membrane domain (Fig. 4A).

Figure 3. Gene maps (not to scale) for a portion of the IR-B section of the apicoplast genomes of sequenced apicomplexan parasites and the closely related chromerid alga Vitrella brassicaformis.

Genomic accession numbers and species names are provided above each map. A small open reading frame (orf105/ycf93) occurs in syntenic positions in each genome. All the photosynthesis related genes (petD, petA, psbC and chlB) from Vitrella brassicaformis have disappeared from the apicoplast genomes and reorientation of the rpo/rps2 operon has occurred in select species.

Figure 4.

A) Alignment of PfYcf93 homologues from the 10 sequenced Plasmodium spp. and the related bird parasite Leucocytozoon caulleri reveals obvious sequence identity and a possible N-terminal extension or an internal initiator methionine in P. falciparum and P. cynomolgi. Putative transmembrane domains are underlined. B) The PfYcf93 homologues of the two Coccidia, Toxoplasma gondii and Eimeria tenella, are well conserved. C) The PfYcf93 homologues of two Piroplasmorida, Theileria parva and Babesia bovis also show clear sequence identity. D) Sequence identity between the putative Vitrella brassicaformis Ycf93 homologue and the apicomplexan proteins such as TpYcf93 is far less obvious.

Amino acid alignment shows a 16 amino acid N-terminal extension in the P. falciparum Ycf93 and a 17 amino acid extension in the Ycf93 orthologue of another primate malaria parasite, P. cynomolgi (Fig. 4A). In both cases this extension is predicted to create a second, N-terminal transmembrane domain in addition to the single, predicted C-terminal transmembrane domain. We note that internal methionines in PfYcf93 and PcYcf93 occur at the same site as the initiator methionines in the Ycf93 proteins from L. caulleri and the other eight malaria parasite species (Fig. 4A), which includes human, bird and rodent infecting species. This internal methionine was initially invoked for PfYcf93 due to the presence of a transcribed and processed trnS gene within the N-terminus of the longer version of PfYcf93 [10]. A trnS gene also occurs in the currently annotated version of PcYcf93 [43] so we consider it most likely that both PfYcf93 and PcYcf93 use this internal methionine for initiation. If PfYcf93 were in fact initiated from the internal methionine, it would not be a substrate for MAP according to the prediction rules [8]. The apparent mass of PfYcf93 (slightly greater than predicted) might suggest that the longer version rather than the shorter version is translated, but the addition of a second transmembrane domain in just these two species seems unlikely, and (as mentioned above) confirmation of the N-terminus and of any processing remains to be made.

The apicoplast genomes of the coccidian apicomplexan parasites Toxoplasma gondii and Eimeria tenella have almost identical architecture and gene content to Plasmodium spp. [46] and likely orthologues of ycf93 occur in these parasites (Fig. 3), though the sequence identity with PfYcf93 proteins is very low (not shown). Nevertheless, TgYcf93 and EtYcf93 are similar size proteins, have a predicted C-terminal trans membrane domain, and are well conserved between these two Coccidia (Fig. 4B). Possible ycf93 orthologues also exist in two members of the Piroplasmorida, namely Babesia bovis [47] and Theileria parva [49] (Fig. 3). The proteins encoded by these small open reading frames lack much overall sequence identity but are relatively similar within lineage (Fig. 4C). Moreover, a predicted C-terminal trans membrane domain exists in TpYcf93 (Fig. 4C), and the genes are situated in syntenic position to other members of the family (Fig. 3) so we believe them to be orthologous.

It is also possible that a ycf93 orthologue exists in the plastids of the related photosynthetic coral symbiont Vitrella brassicaformis [50], a chromerid alga related to Chromera velia [51]. These algae share a common origin of the plastid with Apicomplexa, but remain photosynthetic [4]. In V. brassicaformis good conservation of the gene order in the plastid DNA compared to the apicoplast genome is evident, particularly in comparison with the apicoplast of B. bovis, the key difference in this region being the obvious loss of the photosynthesis genes (petD, petA, psbC and chlB) in the parasite genome (Fig. 3). A small open reading frame, situated between rpl20 and rpoB in V. brassicaformis [4], might be an orthologue of apicoplast ycf93 (Fig. 3), but it shares only modest sequence identity (Fig. 4D), and, unlike all the orthologues in Apicomplexa, is not predicted to contain any trans membrane domain. Drastic rearrangement of the plastid genome in C. velia [4] prevents any identification of putative Ycf93 homologues.

Synteny comparison between the apicoplast genomes and the plastid genome of V. brassicaformis in the ycf93 region indicate that the rpo/rps2 operon underwent reorientation(s) (Fig. 3). The alga V. brassicaformis and the two Piroplasmorida (B. bovis and T. parva) share the same orientation of this operon, but the Haemosporida (Plasmodium and Leucocytozoon) and the Coccidia (Toxoplasma and Eimeria), which share an almost identical architecture [44], have the reverse orientation (Fig. 3). Rearrangements in plastid genomes are common, and it is difficult to interpret a single reorientation in isolation, especially because the Piroplasmorida apicoplast genomes are unusual in being transcribed off a single strand and presumably underwent substantial rearrangements to achieve this.


We have demonstrated that orf105/ycf93 from the apicoplast genome of P. falciparum encodes a small membrane protein that likely resides in the inner membrane of the apicoplast and undergoes dramatic turnover during the asexual red blood cell life cycle of the parasite. The complete disappearance of this protein after schizogony, and its putative location in the inner apicoplast membrane, might suggest a role in apicoplast biogenesis, but sequence comparison does not give any clues to function. Orthologues of orf105/ycf93 occur in all apicoplasts, and perhaps the plastid of the related photosynthetic coral symbiont V. brassicaformis. In keeping with plastid gene nomenclature convention [11] we elevate the gene from orf status to ycf (hypothetical chloroplast open reading frame) status as a protein encoded in plastids of multiple organisms, and we occupy the next available number ycf93.

Materials and Methods

Parasite Culture and Drug Treatment

Plasmodium falciparum strains 3D7, D10, mitoYFP/apicoRFP [16], and KAHRP-GFP (Wickham et al., EMBO J 2001) were in vitro cultured using standard techniques [52]. We thank the Australian Red Cross for red blood cells. Parasite synchronization was done using sequential sorbitol lysis as previously described [3]. Parasites used were isolated from red blood cells by incubating with 0.15% saponin and 0.1% BSA in PBS at 4°C followed by extensive washing with PBS.

Drug trials were carried out on tightly synchronized parasites using a modified version of the SYBRgreen assay [3], [53]. IC50 values were calculated using the four-component inhibition model in Graphpad Prism.

For microscopy and Western analysis of drug treated parasites, inhibitors were added to double synchronised parasites within 4 hours after invasion of a new host cell.

Peptide Antisera

The peptide NILLKSKNSNNY was selected based on an analysis of the antigenicity and hydrophobicity of the amino acid sequence of PfYcf93 using VectorNTI (Invitrogen). The peptide was compared to the P. falciparum genome and found to be unique for sequences >6 amino acids in length. The peptide was conjugated to Diphtheria toxin (Mimotopes) and used to generate polyclonal goat serum (Antibodies Australia). Antibodies were affinity-purified from serum using immobilized peptide as described [54].

Western Blotting

Protein extraction and Western blotting were done as previously described [54]. For the competition assay, unconjugated PfYcf93 peptide (Mimotopes) was added to affinity-purified antibodies immediately prior to probing the membrane. Triton X-114 membrane partitioning and subsequent Western blot analysis was carried out as previously described [55]. Affinity purified anti-PfYcf93, anti-MSP1-19 [56], anti-AMA1 [18], anti-MSP8 [17], and anti-BiP [57] antibodies were used at 5000∶1, 2000∶1, 2000∶1, 1000∶1 and 1000∶1 dilutions, respectively.

Immunofluorescence Assay

Parasite fixation and labelling was carried out as previously described [27] except for the PfYcf93 assay in which cell permeabilization and subsequent washing was carried out at 60°C. Affinity purified goat anti-PfYcf93, rabbit anti-ACP [12] antibodies were use at 250∶1 and 500∶1 respectively. Alexafluor conjugated anti-goat 488 and anti-rabbit 543 (Invitrogen) were used at 1000∶1 dilution. Nuclei were stained with Hoechst 33342. Images were collected using a Leica SP2 confocal microscope and assembled for publication using Adobe Photoshop.


Protein sequences were aligned with ClustalW2 using default parameters [58]. Transmembrane domain predictions were made with THHMM version 2.0 [59].

Author Contributions

Conceived and designed the experiments: CDG GIM. Performed the experiments: CDG GIM. Analyzed the data: CDG GIM. Wrote the paper: GIM.


  1. 1. Tan KR, Magill AJ, Parise ME, Arguin PM (2011) Centers for Disease C, (2011) et al. Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis. Am J Trop Med Hyg 84: 517–531.
  2. 2. Krishna S, Staines HM (2012) Non-Antifolate Antibiotics: Clindamycin, Doxycycline, Azithromycin and Fosmidomycin. In: Staines HM, Krisha S, editors. Treatment and Prevention of Malaria: Antimalarial Drug Chemistry, Action and Use: Springer. pp. 141–156.
  3. 3. Goodman CD, Su V, McFadden GI (2007) The effects of anti-bacterials on the malaria parasite Plasmodium falciparum. Mol Biochem Parasitol 152: 181–191.
  4. 4. Janouskovec J, Horak A, Obornik M, Lukes J, Keeling PJ (2010) A common red algal origin of the apicomplexan, dinoflagellate, and heterokont plastids. Proc Natl Acad Sci U S A 107: 10949–10954.
  5. 5. McFadden GI, Waller RF (1997) Plastids in parasites of humans. BioEssays 19: 1033–1040.
  6. 6. Okamoto N, McFadden GI (2008) The mother of all parasites. Future Microbiol 3: 391–395.
  7. 7. Fichera ME, Roos DS (1997) A plastid organelle as a drug target in apicomplexan parasites. Nature 390: 407–409.
  8. 8. Wilson RJM, Denny PW, Preiser PR, Rangachari K, Roberts K, et al. (1996) Complete gene map of the plastid-like DNA of the malaria parasite Plasmodium falciparum. J Mol Biol 261: 155–172.
  9. 9. El Bakkouri M, Pow A, Mulichak A, Cheung KL, Artz JD, et al. (2010) The Clp chaperones and proteases of the human malaria parasite Plasmodium falciparum. J Mol Biol 404: 456–477.
  10. 10. Preiser P, Williamson DH, Wilson RJ (1995) tRNA genes transcribed from the plastid-like DNA of Plasmodium falciparum. Nucl Acids Res 23: 4329–4336.
  11. 11. Hallick RB, Bairoch A (1994) Proposals for the Naming of Chloroplast Genes. III. Nomenclature for Open Reading Frames Encoded in Chloroplast Genomes. Plant Mol Biol Reporter 12: S29–S30.
  12. 12. Waller RF, Cowman AF, Reed MB, McFadden GI (2000) Protein trafficking to the plastid in Plasmodium falciparum is via the secretory pathway. EMBO J 19: 1794–1802.
  13. 13. Bordier C (1981) Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem 256: 1604–1607.
  14. 14. Ralph SA, van Dooren GG, Waller RF, Crawford MJ, Fraunholz MJ, et al. (2004) Metabolic maps and functions of the Plasmodium falciparum apicoplast. Nat Rev Microbiol 2: 203–216.
  15. 15. Zhang YJ, Tian HF, Wen JF (2009) The evolution of YidC/Oxa/Alb3 family in the three domains of life: a phylogenomic analysis. BMC Evol Biol 9: 137.
  16. 16. van Dooren GG, Marti M, Tonkin CJ, Stimmler LM, Cowman AF, et al. (2005) Development of the endoplasmic reticulum, mitochondrion and apicoplast during the asexual life cycle of Plasmodium falciparum. Mol Microbiol 57: 405–419.
  17. 17. Drew DR, Sanders PR, Crabb BS (2005) Plasmodium falciparum merozoite surface protein 8 is a ring-stage membrane protein that localizes to the parasitophorous vacuole of infected erythrocytes. Infect Immun 73: 3912–3922.
  18. 18. Triglia T, Healer J, Caruana SR, Hodder AN, Anders RF, et al. (2000) Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species. Mol Microbiol 38: 706–718.
  19. 19. Kato Y, Sakamoto W (2013) Plastid protein degradation during leaf development and senescence: Role of proteases and chaperones. Advances in Photosynthesis and Respiration 36: 453–477.
  20. 20. van Dooren GG, Su V, D'Ombrain MC, McFadden GI (2002) Processing of an apicoplast leader sequence in Plasmodium falciparum and the identification of a putative leader cleavage enzyme. J Biol Chem 277: 23612–23619.
  21. 21. Ponpuak M, Klemba M, Park M, Gluzman IY, Lamppa GK, et al. (2007) A role for falcilysin in transit peptide degradation in the Plasmodium falciparum apicoplast. Mol Microbiol 63: 314–334.
  22. 22. Rathore S, Sinha D, Asad M, Bottcher T, Afrin F, et al. (2010) A cyanobacterial serine protease of Plasmodium falciparum is targeted to the apicoplast and plays an important role in its growth and development. Mol Microbiol 77: 873–890.
  23. 23. Lin W, Chan M, Sim TS (2009) Atypical caseinolytic protease homolog from Plasmodium falciparum possesses unusual substrate preference and a functional nuclear localization signal. Parasitol Res 105: 1715–1722.
  24. 24. Giglione C, Meinnel T (2001) Organellar peptide deformylases: universality of the N-terminal methionine cleavage mechanism. Trends Plant Sci 6: 566–572.
  25. 25. Giglione C, Vallon O, Meinnel T (2003) Control of protein life-span by N-terminal methionine excision. Embo J 22: 13–23.
  26. 26. Gardner MJ, Hall N, Fung E, White O, Berriman M, et al. (2002) Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419: 498–511.
  27. 27. Tonkin CJ, Van Dooren GG, Spurck TP, Struck NS, Good RT, et al. (2004) Localization of organellar proteins in Plasmodium falciparum using a novel set of transfection vectors and a new immunofluorescence fixation method. Mol Biochem Parasitol 137: 13–21.
  28. 28. Giglione C, Pierre M, Meinnel T (2000) Peptide deformylase as a target for new generation, broad spectrum antimicrobial agents. Mol Microbiol 36: 1197–1205.
  29. 29. Giglione C, Meinnel T (2002) The situation on antimicrobial agents and chemotherapy in 2002: Highlights of the 42nd ICAAC. Expert Opin Ther Targets 6: 691–697.
  30. 30. Madison V, Duca J, Bennett F, Bohanon S, Cooper A, et al. (2002) Binding affinities and geometries of various metal ligands in peptide deformylase inhibitors. Biophys Chem 101–102: 239–247.
  31. 31. Clements JM, Beckett RP, Brown A, Catlin G, Lobell M, et al. (2001) Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor. Antimicrob Agents Chemother 45: 563–570.
  32. 32. Molteni V, He X, Nabakka J, Yang K, Kreusch A, et al. (2004) Identification of novel potent bicyclic peptide deformylase inhibitors. Bioorg Med Chem Lett 14: 1477–1481.
  33. 33. Wiesner J, Sanderbrand S, Altincicek B, Beck E, Jomaa H (2001) Seeking new targets for antiparasitic agents. Trends Parasitol 17: 7–8.
  34. 34. Bracchi-Ricard V, Nguyen KT, Zhou Y, Rajagopalan PTR, Chakrabarti D, et al. (2001) Characterization of an eukaryotic peptide deformylase from Plasmodium falciparum. Archives of Biochemistry and Biophysics 396: 162–170.
  35. 35. Dahl EL, Rosenthal PJ (2007) Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast. Antimicrob Agents Chemother 51: 3485–3490.
  36. 36. Dahl EL, Rosenthal PJ (2008) Apicoplast translation, transcription and genome replication: targets for antimalarial antibiotics. Trends Parasitol 24: 279–284.
  37. 37. Dahl EL, Shock JL, Shenai BR, Gut J, DeRisi JL, et al. (2006) Tetracyclines specifically target the apicoplast of the malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother 50: 3124–3131.
  38. 38. Nair SC, Brooks CF, Goodman CD, Strurm A, McFadden GI, et al. (2011) Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii. J Exp Med 208: 1547–1559.
  39. 39. Jomaa H, Wiesner J, Sanderbrand S, Altincicek B, Weidemeyer C, et al. (1999) Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science 285: 1573–1576.
  40. 40. Yeh E, DeRisi J (2011) Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum. PLoS Biology 9: e1001138.
  41. 41. Wellner D, Panneerselvam C, Horecker BL (1990) Sequencing of peptides and proteins with blocked N-terminal amino acids: N-acetylserine or N-acetylthreonine. Proc Natl Acad Sci U S A 87: 1947–1949.
  42. 42. Arisue N, Hashimoto T, Mitsui H, Palacpac NM, Kaneko A, et al. (2012) The Plasmodium apicoplast genome: conserved structure and close relationship of P. ovale to rodent malaria parasites. Mol Biol Evol 29: 2095–2099.
  43. 43. Sato S, Sesay AK, Holder AA (2013) The unique structure of the apicoplast genome of the rodent malaria parasite Plasmodium chabaudi chabaudi. PLoS One 8: e61778.
  44. 44. Imura T, Sato S, Sato Y, Sakamoto D, Isobe T, et al.. (2013) The apicoplast genome of Leucocytozoon caulleryi, a pathogenic apicomplexan parasite of the chicken. Parasitol Res published online 04 December 2013 DOI 10.1007/s00436-013-3712-9.
  45. 45. Cai X, Fuller AL, McDougald LR, Zhu G (2003) Apicoplast genome of the coccidian Eimeria tenella. Gene 321: 39–46.
  46. 46. Köhler S, Delwiche CF, Denny PW, Tilney LG, Webster P, et al. (1997) A plastid of probable green algal origin in apicomplexan parasites. Science 275: 1485–1488.
  47. 47. Brayton KA, Lau AO, Herndon DR, Hannick L, Kappmeyer LS, et al. (2007) Genome sequence of Babesia bovis and comparative analysis of apicomplexan hemoprotozoa. PLoS Pathog 3: 1401–1413.
  48. 48. Lau AO, McElwain TF, Brayton KA, Knowles DP, Roalson EH (2009) Babesia bovis: a comprehensive phylogenetic analysis of plastid-encoded genes supports green algal origin of apicoplasts. Exp Parasitol 123: 236–243.
  49. 49. Gardner MJ, Bishop R, Shah T, de Villiers EP, Carlton JM, et al. (2005) Genome sequence of Theileria parva, a bovine pathogen that transforms lymphocytes. Science 309: 134–137.
  50. 50. Obornik M, Modry D, Lukes M, Cernotikova-Stribrna E, Cihlar J, et al. (2012) Morphology, ultrastructure and life cycle of Vitrella brassicaformis n. sp., n. gen., a novel chromerid from the Great Barrier Reef. Protist 163: 306–323.
  51. 51. Moore RB, Obornik M, Janouskovec J, Chrudimsky T, Vancova M, et al. (2008) A photosynthetic alveolate closely related to apicomplexan parasites. Nature 451: 959–963.
  52. 52. Trager W, Jensen JB (1976) Human malaria parasites in continuous culture. Science 193: 673–675.
  53. 53. Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M (2004) Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother 48: 1803–1806.
  54. 54. Mullin KA, Lim L, Ralph SA, Spurck TP, Handman E, et al. (2006) Membrane transporters in the relict plastid of malaria parasites. Proc Natl Acad Sci U S A 103: 9572–9577.
  55. 55. Kalanon M, Tonkin CJ, McFadden GI (2009) Characterization of two putative protein translocation components in the apicoplast of Plasmodium falciparum. Eukaryot Cell 8: 1146–1154.
  56. 56. Boyle MJ, Richards JS, Gilson PR, Chai W, Beeson JG (2010) Interactions with heparin-like molecules during erythrocyte invasion by Plasmodium falciparum merozoites. Blood 115: 4559–4568.
  57. 57. Kumar N, Koski G, Harada M, Aikawa M, Zheng H (1991) Induction and localization of Plasmodium falciparum stress proteins related to the heat shock protein 70 family. Mol Biochem Parasitol 48: 47–58.
  58. 58. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947–2948.
  59. 59. Krogh A, Larsson B, von Heijne G, Sonnhammer EL (2001) Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 305: 567–580.